Find a Tender
complete
Official procurement procedure
Manufacture of Sodium Dichloroacetate Capsules
Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University Of Edinburgh: "Manufacture of Sodium Dichloroacetate Capsules". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | University Of Edinburgh | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: University Of Edinburgh
Market Analytics
Derived from OCDS awards & bid statistics
Published history for University Of Edinburgh. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 230 active published awards; 205 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity Of Edinburgh | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published10 Apr 2026, 16:51 BST | Last source update10 Apr 2026, 16:51 BST | Recurring procurementNot published |
ClassificationMedical equipments, pharmaceuticals and personal care products | ||
Delivery area | ||
OCIDocds-h6vhtk-06805b | ||
What is being bought
The University plans to award Catalent Nottingham Limited the contract for the Manufacture of Sodium Dichloroacetate Capsules to support clinical studies.
What changed
From the official release history
- Status changed to complete
10 Apr 2026, 16:51 BST - Official notice release published
10 Apr 2026, 16:51 BST - Buyer information updated
10 Apr 2026, 16:51 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedThe university intends to award the contract for the manufacture of drugs to support clinical studies. The drug manufacturer has a confidential disclosure agreement (CDA) with Catalent Nottingham in the UK.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
10 Apr 2026, 16:51 BST - Award active
Not published · Not published - Contract active
Signed 10 Apr 2026, 00:00 BST · £192,482
Commercial outcome and competition
Awards Catalent Not published · Not published · active |
Contracts Contract £192,482 · signed 10 Apr 2026, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
University Of Edinburgh
Contracting authority GB-FTS-2023Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleDue to the proprietary nature of the drug's active ingredient and the manufacturer's sole relationship with the supplier, competition is absent for technical reasons. |